Top Articles
Volume 111, Number 5- PROGRESS IN HEMATOLOGY –
●Guest editorial: B1 cells: their ontogeny and malignant counterpart (by Naoyuki Katayama)
●The ontogeny of murine B-1a cells (by Momoko Yoshimoto)
●Ontogeny of human B1 cells (by Yuki Kageyama and Naoyuki Katayama)
●Pathophysiology of chronic lymphocytic leukemia and human B1 cell development (by Yoshikane Kikushige)
●Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal? (by Junji Suzumiya and Jun Takizawa)
Volume 111, Number 4- PROGRESS IN HEMATOLOGY –
● Introduction by the Guest Editor: Recent advances in biology and treatment of multiple myeloma (by Hirokazu Tanaka)
● Molecular basis of clonal evolution in multiple myeloma (by Yusuke Furukawa and Jiro Kikuchi)
● Latest treatment strategies aiming for a cure in transplant-eligible multiple myeloma patients: how I cure younger MM patients with lower cost (by Kenshi Suzuki)
● Clinical value of measurable residual disease testing for multiple myeloma and implementation in Japan (by Hiroyuki Takamatsu)
● Chimeric antigen receptor T-cell therapy for multiple myeloma (by Naoki Hosen)
Volume 111, Number 2- PROGRESS IN HEMATOLOGY -
●Progress in elucidation of molecular pathophysiology and its application in therapeutic decision-making for myeloproliferative neoplasms (by Katsuto Takenaka)
●Progress in elucidation of molecular pathophysiology of myeloproliferative neoplasms and its application to therapeutic decisions (by Ruochen Jia and Robert Kralovics)
●Mutational profiling in myelofibrosis: implications for management (by Prithviraj Bose and Srdan Verstovsek)
●The role of calreticulin mutations in myeloproliferative neoplasms (by Marito Araki and Norio Komatsu)
●The role of driver mutations in myeloproliferative neoplasms: insights from mouse models (by Kotaro Shide)
Volume 111, Number 1- PROGRESS IN HEMATOLOGY -
●Current progress and future direction in the treatment for hemophilia (by Midori Shima)
●Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity (by Takehisa Kitazawa and Midori Shima)
●Advances in gene therapy for hemophilia: basis, current status, and future perspectives (by Tsukasa Ohmori)
●Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia (by Pratima Chowdary)
Volume 110, Number 2- PROGRESS IN HEMATOLOGY -
●Epigenetic abnormalities and therapies for hematological malignancies (by Toshio Kitamura)
●New insights into the biology of acute myeloid leukemia with mutated NPM1 (by Lorenzo Brunetti, et al.)
●Clinical update on hypomethylating agents (by Matthieu Duchmann and Raphael Itzykson)
●Deregulated Polycomb functions in myeloproliferative neoplasms (by Goro Sashida, et al.)
●Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms (by Shuhei Asada and Toshio Kitamura)
Volume 110, Number 1- PROGRESS IN HEMATOLOGY -
●Guest Editorial: Are “alternative” stem cell sources still alternative in the new era? (by Junya Kana)
●Effect of antithymocyte globulin on HLA-mismatched unrelated transplantation (by Koji Kawamura)
●HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide (by Junichi Sugita)
●Single cord blood transplantation in Japan; expanding the possibilities of CBT (by Hisashi Yamamoto)
●Current and future perspectives on allogeneic transplantation using ex vivo expansion or manipulation of umbilical cord blood cells (by Ko K. Maung and Mitchell E. Horwitz)
Volume 109, Number 1- PROGRESS IN HEMATOLOGY -
●Molecular pathogenesis of leukemia and leukemic stem cells (LSCs) (by Masahiro Kizaki)
●Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia (by Tze King Tan, et al.)
●Metabolism as master of hematopoietic stem cell fate (by Kyoko Ito, et al.)
●Targeting transcription factors in acute myeloid leukemia (by Hisashi Takei and Susumu S. Kobayashi)
●What do the lineage tracing studies tell us? Consideration for hematopoietic stem cell origin, dynamics, and leukemia-initiating cells (by Nathalia Azevedo Portilho, et al.)
